Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hull

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Journal of the International AIDS Society|October 28, 2022
Examining provincial PrEP coverage and characterizing PrEP awareness and use among gay, bisexual and other men who have sex with men in Vancouver, Toronto and Montreal, 2017-2020Jordan M Sang, Kate McAllister, Lu Wang, et al.
Mbio|March 30, 2026
Non-suppressible HIV viremia sustained by clonally expanded CD4+ T cells harboring a genomically defective provirus with an immune-evasive protein expression profileF Harrison Omondi, Yurou Sang, Winnie Dong, et al.
Viruses|February 28, 2023
SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)Yulia Alexandrova, Alexis Yero, Ralph-Sydney Mboumba Bouassa, et al.
BMJ Open|May 26, 2026
Incidence and risk factors of <i>C. trachomatis</i>, <i>N. gonorrhoeae</i> and syphilis among a cohort of urban Canadian gay, bisexual and other men who have sex with men, 2017-2023: informing the potential impact of doxycycline prophylaxisGilles Lambert, Alain Fourmigue, Milada Dvorakova, et al.
BMJ Open|December 17, 2021
CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort studyCecilia T Costiniuk, Joel Singer, Marc-André Langlois, et al.
Antiviral Therapy|December 8, 2016
A comparison of virological suppression and rebound between Indigenous and non-Indigenous persons initiating combination antiretroviral therapy in a multisite cohort of individuals living with HIV in CanadaAnita C Benoit, Jaime Younger, Kerrigan Beaver, et al.
AIDS (London, England)|July 19, 2023
Reinfection incidence and risk among people treated for recent hepatitis C virus infectionMarianne Martinello, Joanne M Carson, Marc Van Der Valk, et al.
Viruses|May 25, 2024
T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral TherapySneha Datwani, Rebecca Kalikawe, Rachel Waterworth, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|June 17, 2017
Increased mortality among Indigenous persons in a multisite cohort of people living with HIV in CanadaAnita C Benoit, Jaime Younger, Kerrigan Beaver, et al.
Progress in Community Health Partnerships : Research, Education, and Action|January 8, 2021
Building Bridges: Describing a Process for Indigenous Engagement in EpidemiologyAnita C Benoit, Denise Jaworsky, Roberta Price, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Journal of the International AIDS Society|October 28, 2022
Examining provincial PrEP coverage and characterizing PrEP awareness and use among gay, bisexual and other men who have sex with men in Vancouver, Toronto and Montreal, 2017-2020Jordan M Sang, Kate McAllister, Lu Wang, et al.
Mbio|March 30, 2026
Non-suppressible HIV viremia sustained by clonally expanded CD4+ T cells harboring a genomically defective provirus with an immune-evasive protein expression profileF Harrison Omondi, Yurou Sang, Winnie Dong, et al.
Viruses|February 28, 2023
SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)Yulia Alexandrova, Alexis Yero, Ralph-Sydney Mboumba Bouassa, et al.
BMJ Open|May 26, 2026
Incidence and risk factors of <i>C. trachomatis</i>, <i>N. gonorrhoeae</i> and syphilis among a cohort of urban Canadian gay, bisexual and other men who have sex with men, 2017-2023: informing the potential impact of doxycycline prophylaxisGilles Lambert, Alain Fourmigue, Milada Dvorakova, et al.
BMJ Open|December 17, 2021
CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort studyCecilia T Costiniuk, Joel Singer, Marc-André Langlois, et al.
Antiviral Therapy|December 8, 2016
A comparison of virological suppression and rebound between Indigenous and non-Indigenous persons initiating combination antiretroviral therapy in a multisite cohort of individuals living with HIV in CanadaAnita C Benoit, Jaime Younger, Kerrigan Beaver, et al.
AIDS (London, England)|July 19, 2023
Reinfection incidence and risk among people treated for recent hepatitis C virus infectionMarianne Martinello, Joanne M Carson, Marc Van Der Valk, et al.
Viruses|May 25, 2024
T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral TherapySneha Datwani, Rebecca Kalikawe, Rachel Waterworth, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|June 17, 2017
Increased mortality among Indigenous persons in a multisite cohort of people living with HIV in CanadaAnita C Benoit, Jaime Younger, Kerrigan Beaver, et al.
Progress in Community Health Partnerships : Research, Education, and Action|January 8, 2021
Building Bridges: Describing a Process for Indigenous Engagement in EpidemiologyAnita C Benoit, Denise Jaworsky, Roberta Price, et al.
Pageof 13